Nov 18,2020 Twist Bioscience Ranked 60th Fastest Growing Company in North America on Deloitte’s 2020 Fast 500™ read more >>
Nov 12,2020 Twist Bioscience, Illumina and Western Digital Form Alliance with Microsoft to Advance Data Storage in DNA read more >>
Nov 11,2020 Immune-Onc Therapeutics Announces Orphan Drug Designation of IO-202 (Anti-LILRB4) for Treatment of AML and Poster Presentation at ASH 2020 read more >>
Nov 10,2020 Aravive to Receive $12 Million Signing Payment, up to an Additional $207 Million in Future Milestone Payments plus Tiered Royalties read more >>
Nov 10,2020 Immune-Onc Therapeutics to Present Preclinical Data for IO-108, a Novel Antagonist Antibody Targeting LILRB2 (ILT4) in Solid Tumors, at SITC 2020 read more >>
Oct 15,2020 Apexigen’s APX005M Granted Orphan Drug Designations for the Treatment of Esophageal and Gastroesophageal Junction Cancer and for the Treatment of Pancreatic Cancer read more >>